Want to see HK:1833 full AI Analyst Report?
1833 Stock Chart & Stats
HK$12.05
-HK$0.05(-0.79%)
At close: 4:00 PM EST
HK$12.05
-HK$0.05(-0.79%)
Day’s Range― - ―
52-Week RangeHK$6.57 - HK$24.40
Previous CloseN/A
Volume17.15M
Average Volume (3M)17.30M
Market Cap
HK$16.10B
Enterprise ValueHK$22.21K
Total Cash (Recent Filing)HK$6.97B
Total Debt (Recent Filing)HK$39.81M
Price to Earnings (P/E)37.9
Beta1.37
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding2,161,443,600
10 Day Avg. Volume8,945,339
30 Day Avg. Volume17,297,252
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)2.69
Price to Sales (P/S)4.88
P/FCF Ratio68.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$15.17Price Target Upside25.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.22
Revenue Forecast (FY)HK$5.85B
Bulls Say, Bears Say
Bulls Say
Turnaround To ProfitabilityThe material shift from multi-year losses to positive net income in 2024 and stronger profit in 2025 indicates the business has crossed an operational inflection point. Sustained profitability improves reinvestment capacity, strengthens creditor and partner confidence, and provides a more durable base for scaling services and improving unit economics over the next several quarters.
Very Low LeverageExtremely low debt levels (debt-to-equity ~0.4% in 2025) give the company financial flexibility to fund product development, partnerships, or M&A without stressing interest coverage. A conservative capital structure reduces solvency risk, supports investment through cycles, and enhances long-term strategic optionality.
Improving Cash GenerationThe shift to positive operating and free cash flow, and strong free cash flow growth in 2025, signals higher earnings quality and internal funding capacity. Consistent positive FCF enables self-funded growth, reduces reliance on external capital, and supports durable investment in platform capabilities and customer acquisition over multiple quarters.
Bears Say
Revenue VolatilityMaterial top-line swings across 2022–2025 reveal inconsistent demand and execution risks. Persistent revenue volatility undermines predictable cash flow and margin planning, complicates long-range capacity and investment decisions, and raises the bar for management to demonstrate sustainable, repeatable growth.
Uneven Cash ConversionAlthough cash flow turned positive, uneven conversion and historically deep outflows mean operating cash remains sensitive to working-capital swings and non-cash items. This increases the risk that earnings may not reliably translate into spendable cash in weaker quarters, limiting predictable funding for strategic initiatives.
Swings In Reported EquitySignificant year-to-year swings in reported equity suggest capitalization changes or accounting items that complicate trend analysis. Such variability can obscure true return metrics, complicate shareholder equity assessment, and increase the chance that one-off adjustments affect reported profitability and leverage measures.
Ping An Healthcare and Technology Company News
1833 FAQ
What was Ping An Healthcare and Technology Company Limited’s price range in the past 12 months?
Ping An Healthcare and Technology Company Limited lowest stock price was HK$6.57 and its highest was HK$24.40 in the past 12 months.
What is Ping An Healthcare and Technology Company Limited’s market cap?
Ping An Healthcare and Technology Company Limited’s market cap is HK$16.10B.
When is Ping An Healthcare and Technology Company Limited’s upcoming earnings report date?
Ping An Healthcare and Technology Company Limited’s upcoming earnings report date is Aug 18, 2026 which is in 32 days.
How were Ping An Healthcare and Technology Company Limited’s earnings last quarter?
Currently, no data Available
Is Ping An Healthcare and Technology Company Limited overvalued?
According to Wall Street analysts Ping An Healthcare and Technology Company Limited’s price is currently Undervalued.
Does Ping An Healthcare and Technology Company Limited pay dividends?
Ping An Healthcare and Technology Company Limited pays a Notavailable dividend of HK$9.7 which represents an annual dividend yield of N/A. See more information on Ping An Healthcare and Technology Company Limited dividends here
What is Ping An Healthcare and Technology Company Limited’s EPS estimate?
Ping An Healthcare and Technology Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ping An Healthcare and Technology Company Limited have?
Ping An Healthcare and Technology Company Limited has 2,161,443,600 shares outstanding.
What happened to Ping An Healthcare and Technology Company Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ping An Healthcare and Technology Company Limited?
Currently, no hedge funds are holding shares in HK:1833
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ping An Healthcare and Technology Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$15.17 (25.86% Upside)
HK$15.17 (25.86% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1135.06%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-17.64%
Trailing 12-Months
Company Description
Ping An Healthcare and Technology Company Limited
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical consultations, facilitated hospital referrals and appointment scheduling, inpatient care coordination, and expert second opinions. PAHT also provides standardized consumer healthcare packages, integrating services from a network of medical institutions. Beyond services, the company offers a broad array of products, including pharmaceuticals, health supplements, medical devices, wellness items such as fitness equipment and personal care products, and other miscellaneous goods. Furthermore, PAHT engages users with health management and wellness interaction services, featuring various programs, interactive tools, activities, and personalized content. Its additional operations include medicine marketing, technology services, application development and maintenance, direct hospital and clinic services, and the management of an insurance agency. Established in 2014, Ping An Healthcare and Technology Company Limited maintains its headquarters in Shanghai, China.
1833 Stock 12 Month Forecast
Average Price Target
HK$15.17
▲(25.86% Upside)
Technical Analysis
Dingdang Health Technology Group Ltd.
―
Perfect Medical Health Management Limited
―
Yidu Tech, Inc.
―
Medlive Technology Co., Ltd.
―
Xunfei Healthcare Technology Co., Ltd.
―